NIVF Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.620

Open

0.552

VWAP

0.58

Vol

249.67K

Mkt Cap

513.46K

Low

0.552

Amount

143.80K

EV/EBITDA(TTM)

--

Total Shares

982.69K

EV

4.48M

EV/OCF(TTM)

--

P/S(TTM)

0.01

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

Show More

Events Timeline

(ET)

2026-03-02

17:40:00

NewGenIvf Group Files to Sell 100M Class A Ordinary Shares

2026-03-02

08:40:00

NewGenIVF Signs MOU with Women in Web3

2026-02-24 (ET)

2026-02-24

08:50:00

NewGenIVF Completes Financial Transformation, Achieves $28 Million in Net Assets

2026-02-04 (ET)

2026-02-04

08:40:00

NewGenIVF Group Launches Inaugural Tokenized Bond Issuance

2026-01-27 (ET)

2026-01-27

08:40:00

NewGenIVF Group Initiates Share Repurchase Program

2026-01-23 (ET)

2026-01-23

20:00:00

NewGenIvf Group Ltd Trading Halted, News Pending

2026-01-21 (ET)

2026-01-21

08:50:00

NewGenIVF Appoints Joshua Chu as Senior Counsel to Launch $30M Tokenized Bond

2025-12-12 (ET)

2025-12-12

08:40:00

NewGenIVF Converts Ras Al Khaimah Project Structure, Expected Profit Increases to $123 Million

2025-12-02 (ET)

2025-12-02

08:11:00

NewGen Reports $3.3M Revenue for 9M, $17.5M Net Income

2025-11-10 (ET)

2025-11-10

08:39:44

NewGenIvf Group Launches Share Repurchase Program Worth Up to $2 Million

News

Newsfilter

03-02Newsfilter

NewGenIVF Partners with WiW3 to Enhance Women's Health Awareness

Newsfilter

02-24Newsfilter

NewGenIVF Group's Remarkable Financial Transformation

Newsfilter

02-04Newsfilter

NewGen Successfully Launches Inaugural Tokenized Bond Campaign

Globenewswire

01-21Globenewswire

NewGenIVF Appoints Legal Expert to Drive $30 Million Tokenized Bond Issuance

Newsfilter

2025-12-12Newsfilter

NewGenIVF Converts Project to Joint Development, Expected Profit Increases to $123 Million

SeekingAlpha

2025-12-02SeekingAlpha

NewGenIvf Reports GAAP EPS of $96.76 and Revenue of $3.30 Million

Valuation Metrics

The current forward P/E ratio for NewGenIvf Group Ltd (NIVF.O) is 0.25, compared to its 5-year average forward P/E of 0.06. For a more detailed relative valuation and DCF analysis to assess NewGenIvf Group Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.06

Current PE

0.25

Overvalued PE

0.31

Undervalued PE

-0.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.02

Overvalued PS

0.02

Undervalued PS

-0.01

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

Low float stock screener

Intellectia · 1484 candidates

List Exchange: XNYS, XNAS, XASEFloating Shares: <= 20,000,000

Ticker

Name

Market Cap$

Lion Group Holding Ltd

638.91K

La Rosa Holdings

711.55K

Erayak Power Solution Group Inc

831.04K

NewGenIvf Group Ltd

864.77K

Quhuo Ltd

948.08K

Biodexa Pharmaceuticals PLC

1.01M

i need quick scalp trades under a dollar

Intellectia · 2 candidates

Price: $0.10 - $1.00Price Change Pct: $3.00 - $25.00Relative Vol: >= 2Three Min Rate Of Change: >= 0.5%Monthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

IO Biotech Inc

22.60M

NewGenIvf Group Ltd

889.24K

Good cheap stock to buy

Intellectia · 746 candidates

Market Cap: <= 2.00BPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 15

Ticker

Name

Market Cap$

NewGenIvf Group Ltd

553.20K

Lion Group Holding Ltd

755.53K

Icon Energy Corp

1.57M

Interactive Strength Inc

1.70M

Boxlight Corp

1.73M

Direct Digital Holdings Inc

1.74M

stocks under $1 to daytrade today

Intellectia · 15 candidates

Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000

Ticker

Name

Market Cap$

TRX Gold Corp

271.29M

BRC Inc

247.13M

Rackspace Technology Inc

204.93M

Humacyte Inc

189.14M

Atlasclear Holdings Inc

36.30M

Cosmos Health Inc

19.42M

stocks under five dollars with low RSI

Intellectia · 11 candidates

Market Cap: <= 2.00BPrice: <= $5.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000Rsi 14: <= 30

Ticker

Name

Market Cap$

Diginex Ltd

292.33M

Aptera Motors Corp

90.95M

Surgepays Inc

25.72M

IO Biotech Inc

14.94M

J-Long Group Ltd

13.50M

MetaVia Inc

9.24M

oversold stocks under five dollars

Intellectia · 11 candidates

Price: <= $5.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000Rsi 14: <= 30

Ticker

Name

Market Cap$

Diginex Ltd

292.33M

Aptera Motors Corp

90.95M

Surgepays Inc

25.72M

IO Biotech Inc

14.94M

J-Long Group Ltd

13.50M

MetaVia Inc

9.24M

day trade stocks under $1 today

Intellectia · 15 candidates

Price: <= $1.00Relative Vol: >= 1.50Weekly Average Turnover: >= 1,000,000

Ticker

Name

Market Cap$

TRX Gold Corp

271.29M

BRC Inc

247.13M

Rackspace Technology Inc

204.93M

Humacyte Inc

189.14M

Atlasclear Holdings Inc

36.30M

Cosmos Health Inc

19.42M

current bearish stocks using patterns

Intellectia · 18 candidates

Gap Pattern: GapDownMoving Average Relationship: PriceBelowMA5, PriceBelowMA20Candlestick Pattern: DescendingTriangle, HeadAndShoulder, BlackCandlestickSupport Resistance Relationship: PriceFallBelowSupport

Ticker

Name

Market Cap$

Marti Technologies Inc

185.35M

Brilliant Earth Group Inc

162.18M

SUI Group Holdings Ltd

145.37M

Wrap Technologies Inc

127.33M

Toro Corp

121.18M

Aligos Therapeutics Inc

49.23M

Whales Holding NIVF

Trading Trends

People Also Watch

Frequently Asked Questions

What is NewGenIvf Group Ltd (NIVF) stock price today?

The current price of NIVF is 0.5553 USD — it has increased 6.32

What is NewGenIvf Group Ltd (NIVF)'s business?

NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. It specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. It has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.

What is the price predicton of NIVF Stock?

Wall Street analysts forecast NIVF stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NIVF is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is NewGenIvf Group Ltd (NIVF)'s revenue for the last quarter?

NewGenIvf Group Ltd revenue for the last quarter amounts to 1.28M USD, decreased -12.94

What is NewGenIvf Group Ltd (NIVF)'s earnings per share (EPS) for the last quarter?

NewGenIvf Group Ltd. EPS for the last quarter amounts to 97.28 USD, decreased -430.88

How many employees does NewGenIvf Group Ltd (NIVF). have?

NewGenIvf Group Ltd (NIVF) has 76 emplpoyees as of March 10 2026.

What is NewGenIvf Group Ltd (NIVF) market cap?

Today NIVF has the market capitalization of 513.46K USD.